In the continuous search for potentially cancer-curing treatments, researchers have turned to engineering cells. They’ve found that modifying immune cells so that they recognize cancer cells, a technique called chimeric antigen receptor (CAR) T-cell therapy, can be effective. One such treatment has already been given the green light by the U.S. Food and Drug Administration. Reprogramming ...